Xconomy | National - Business + Technology in the Exponential Economy

Archives

by in
Entry Blogger Date  ▴ Xconomist Location
SunEthanol Picks Up $25M, New Name; Infinity Pharma Pairs with Purdue Pharma; In-Q-Tel Taps Two Local Firms, & More Boston-Area Deals News Rebecca Zacks 11/24/08 Boston
Ironwood, Flush With Cash, Anticipates Big Year with Constipation Drug Luke Timmerman 11/21/08 Boston
Infinity Snags $75 Million Through Alliance with Purdue Pharma and Mundipharma Luke Timmerman 11/20/08 Boston
Aileron Develops New Class of Drugs To Go Where None Could Before Luke Timmerman 11/07/08 Boston
Aires Pharmaceuticals Emerges from Stealth Mode With Drug for Pulmonary Arterial Hypertension Luke Timmerman 11/05/08 San Diego
Anadys Drug Found Safe in Small Study, Aims to Contend in New Class of Hepatitis C Meds Luke Timmerman 11/01/08 San Diego
Novartis Option Fund Managing Director Says First Responsibility is to Portfolio Companies, Dislikes “Corporate VC” Moniker Ryan McBride 10/31/08 Boston
Vertex Cystic Fibrosis Drug Improves Breathing for 28 Days Luke Timmerman 10/20/08 Boston
Allozyne, Developer of Multiple Sclerosis Drug in Fewer Shots, Poised to Enter Clinical Trials Luke Timmerman 10/16/08 Seattle
Calistoga Builds Cancer Drug Strategy, Hires First CEO, Carol Gallagher Luke Timmerman 10/08/08 Seattle
The Boston-Area Obesity Treatment Cluster: Are Flood Gates Opening for Weight-Loss Drugs and Devices? Ryan McBride 10/08/08 Boston
Forma Buys SolMap Assets Wade Roush 10/02/08 Boston
Indevus Puts New Acromegaly Treatment Head-to-Head with Novartis Treatment in Phase 3 Trial Ryan McBride 09/30/08 Boston
New Biotech Biz Models (and the Tested Bob Langer-Terry McGuire Approach) Emerge at Xconomy Forum Ryan McBride 09/25/08 Boston
Xconomy Forum: A Big Thank You to Our Sponsors, Speakers, and Guests Robert Buderi 09/24/08 Boston
Millennium Enjoying New Era, Novartis Boosting Vaccine Effort, Living Proof Offering Frizz Fighters Online, & More Life Sciences News Rebecca Zacks 09/17/08 Boston
Gilead’s Seattle Crew Awaits FDA Clearance of Cystic Fibrosis Drug, Catalyst for Future Growth Luke Timmerman 09/15/08 Seattle
Novartis To Beef Up Vaccine Research in Cambridge Luke Timmerman 09/12/08 Boston
Millennium CEO Dunsire Juggles Growing Pipeline, Works to Maintain Nimble Culture—as New Owner Takeda Makes the Company its Center for Cancer Drug Development Luke Timmerman 09/10/08 Boston
Alnylam Adds Another RNA Approach, Vertex Tackles Hardest Hep C Cases, Zafgen Places Big Bet on Fat Shrinkers, & More Life Sciences News Rebecca Zacks 09/10/08 Boston
Zafgen, Developer of Fat-Shrinking Drugs, Hires Novartis Scientist as New CEO and Emerges From Stealth Mode Luke Timmerman 09/09/08 Boston
British Biotech Antisoma Sees Buyout of Xanthus as Beginning of U.S. Commercial Hub in Cambridge, MA Ryan McBride 09/08/08 Boston
Seattle Genetics’ Medical Point Man, Tom Reynolds, Aims to Capitalize on Hodgkin’s Drug Luke Timmerman 09/08/08 Seattle
Corporate Life Sciences VCs on the Rise in New England—the List Ryan McBride 09/03/08 Boston
Idera Receives Milestone Payment from Novartis For Asthma and Allergy Collaboration Luke Timmerman 09/02/08 Boston
Ariad Pharmaceuticals Edging Toward Becoming a Commercial Cancer Drug Company Luke Timmerman 09/02/08 Boston
After Cutting Deals With Most of the Big Drug Cos, Sermo CEO Offers Health 2.0 Survival Tip: You Will Not Pay Your Bills with “Ads by Google” Ryan McBride 08/28/08 Boston
Announcing Xconomy’s Next Forum: How to Build A Life Sciences Company Robert Buderi 08/25/08 Boston
ProteoStasis Takes Off From $45 Launch Pad, BitWave Receives $10M Transmission, GameLogic Reckons $8M Will Do, & More Deals News Rebecca Zacks 08/25/08 Boston
Vertex Marching Ahead With Cystic Fibrosis Program Luke Timmerman 08/01/08 Boston
Page 1 of 2 next page »
    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2008 Xconomy. All rights reserved. Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.